Kriya Therapeutics lands $100m Series B

Kriya Therapeutics, Inc, a provider of novel technologies and therapeutics in gene therapy, has secured $100 million in Series B financing.

Kriya Therapeutics, Inc, a provider of novel technologies and therapeutics in gene therapy, has secured $100 million in Series B financing. Patient Square Capital led the round.

Source: Press Release